Europe — EMA
Expirobacter (13c-Urea)
Expirobacter is a pharmaceutical product containing 13c-Urea, used for diagnostic purposes. This oral medication is manufactured by Alfasigma S.P.A. in the EU.
Request sourcing
What is 13c-Urea?
Expirobacter is a pharmaceutical product containing 13c-Urea, used for diagnostic purposes. This oral medication is manufactured by Alfasigma S.P.A. in the EU.
What is 13c-Urea used for?
Expirobacter is primarily used in diagnostic procedures to help identify certain conditions related to the digestive system. The active ingredient, 13c-Urea, aids in detecting the presence of specific bacteria. This medication is taken orally and is designed to assist healthcare professionals in their diagnostic evaluations.
What are the side effects of 13c-Urea?
When taken as directed, Expirobacter may cause mild gastrointestinal discomfort in some individuals. Common effects can include bloating or mild abdominal pain. These effects are generally temporary and subside shortly after the diagnostic procedure.
What precautions apply to 13c-Urea?
Expirobacter should be used strictly under medical supervision. Individuals with known allergies to any of the ingredients should avoid this medication. It is important to follow the instructions provided by your healthcare professional to ensure safe and effective use.
What does 13c-Urea interact with?
Expirobacter may interact with certain medications, particularly those that affect the digestive system. It is advisable to inform your healthcare provider about all medications you are currently taking to avoid potential interactions. Alcohol consumption should be avoided during the diagnostic period.



